These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


92 related items for PubMed ID: 2252528

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
    Peig M, Gomis R, Ercilla G, Casamitjana R, Bottazzo GF, Pujol-Borrell R.
    Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
    [Abstract] [Full Text] [Related]

  • 4. Specific immunotherapy in insulin-dependent diabetes mellitus (preliminary report).
    Lohmann D, Bierwolf B, Krug J, Lampeter E, Verlohren HJ.
    Exp Clin Endocrinol; 1986 Aug; 87(3):333-6. PubMed ID: 3536537
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Defect of cellular suppressor function in the pathogenesis of type I diabetes mellitus.
    Lohmann D, Lampeter E, Krug J, Bierwolf B, Verlohren HJ.
    Exp Clin Endocrinol; 1987 Aug; 89(3):340-4. PubMed ID: 2959493
    [Abstract] [Full Text] [Related]

  • 7. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.
    Medina A, Parween S, Ullsten S, Vishnu N, Siu YT, Quach M, Bennet H, Balhuizen A, Åkesson L, Wierup N, Carlsson PO, Ahlgren U, Lernmark Å, Fex M.
    Diabetologia; 2018 Apr; 61(4):896-905. PubMed ID: 29209740
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes.
    Björk E, Berne C, Kämpe O, Wibell L, Oskarsson P, Karlsson FA.
    Diabetes; 1996 Oct; 45(10):1427-30. PubMed ID: 8826981
    [Abstract] [Full Text] [Related]

  • 12. C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.
    Mirel RD, Ginsberg-Fellner F, Horwitz DL, Rayfield EJ.
    Diabetologia; 1980 Sep; 19(3):183-8. PubMed ID: 6997119
    [Abstract] [Full Text] [Related]

  • 13. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA, Suzuki M, Waldeck N, Dodson LE, Slater L, Ong K, Kershnar A, Buckingham B, Golden M.
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.